{"schema_version":"secwatch.filing_event.v1","accession":"0001562762-23-000290","form_type":"8-K","ticker":"CHE","cik":"0000019584","company_name":"CHEMED CORP","filed_at":"2023-07-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.126919+00:00","generated_at":"2026-06-13T02:29:42.613672+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Chemed Q2 revenue up 4.2% to $554M; adjusted EPS $4.71 down 2.7% YoY","bullets":["GAAP diluted EPS $3.51; adjusted diluted EPS $4.71 (down 2.7% YoY).","VITAS net revenue $321M (+7.8%); ADC 18,392 (+6.2%); admissions 15,611 (+5.9%).","Roto-Rooter revenue $233M (-0.2%); adjusted EBITDA $65.9M (-4.5%); margin 28.3%.","No debt; $160M cash; $405M undrawn credit facility; repurchased 25,000 shares for $13.4M.","FY2023 adjusted EPS guidance $19.90-$20.10 vs 2022's $19.75."],"urls":{"canonical":"https://secwatch.observer/filing/0001562762-23-000290","json":"https://secwatch.observer/filing/0001562762-23-000290.json","markdown":"https://secwatch.observer/filing/0001562762-23-000290.md","text":"https://secwatch.observer/filing/0001562762-23-000290.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/19584/000156276223000290/0001562762-23-000290-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/19584/000156276223000290/che-20230630x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T02:29:42.613672+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a5ee2bda71b4f80cf4d3922511f0a34a73c620bc","claim":"CHEMED CORP reported second quarter ended June 30, 2023 results: revenue $554 million, EPS $3.51. Guidance reaffirmed.","evidence_excerpt":"Chemed Corporation (Chemed) (NYSE: CHE ), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its second quarter ended June 30, 2023, versus the comparable prior-year period, as follows:  Consolidated operating results: · Revenue increased 4.2% to $554 million · GAAP Diluted Earnings-per-Share (EPS) of $3.51 · Adjusted Diluted EPS of $4.71, a decrease of 2.7%","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/19584/000156276223000290/0001562762-23-000290-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"second quarter ended June 30, 2023"},{"label":"Revenue","value":"$554 million"},{"label":"EPS","value":"$3.51"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}